2 February 2024
We are excited to share that an article written by our co-founders and co-inventors are accepted by the Annals Singapore - Academy of Medicine.Â
​
In this commentary, our experts share the potential of RNA therapeutics in reaching undruggable targets with minimal off-target effects and high specificity for dermatological conditions.
​
Visit the link to access our open access article.
Comments